By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Lovastatin

Lovastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
4 Min Read
SHARE
3 min read|581 words

What is Lovastatin?

Lovastatin is a cholesterol-lowering medication that belongs to a class of drugs called statins (HMG-CoA reductase inhibitors). It is primarily prescribed to reduce high cholesterol levels and lower the risk of cardiovascular disease in patients with elevated blood lipids. Lovastatin was one of the first statins developed and remains an important option for managing cholesterol disorders.

Uses

Lovastatin is approved for several cardiovascular-related conditions:

  • Primary hypercholesterolemia: Reduces elevated LDL (“bad”) cholesterol and total cholesterol levels in patients with high cholesterol
  • Mixed dyslipidemia: Treats patients with multiple lipid abnormalities, including high cholesterol and triglycerides
  • Primary prevention of coronary heart disease: Reduces cardiovascular risk in patients with elevated cholesterol but no existing heart disease
  • Secondary prevention: Helps prevent future cardiovascular events in patients with established coronary heart disease
  • Familial hypercholesterolemia: Manages inherited conditions that cause extremely high cholesterol levels

How it works

Lovastatin works by blocking an enzyme called HMG-CoA reductase, which is essential for cholesterol production in the liver. By inhibiting this enzyme, lovastatin reduces the liver’s ability to manufacture cholesterol, forcing the body to remove more cholesterol from the bloodstream. This mechanism effectively lowers both total cholesterol and LDL cholesterol levels while potentially providing modest increases in HDL (“good”) cholesterol.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle pain or weakness
  • Nausea and digestive upset
  • Diarrhea or constipation
  • Dizziness
  • Sleep disturbances
  • Fatigue
  • Skin rash

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (signs of rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (liver problems)
  • Severe abdominal pain
  • Memory problems or confusion

Warnings and precautions

  • Liver disease: Patients with active liver disease or elevated liver enzymes should avoid lovastatin, as it can worsen liver function
  • Pregnancy and breastfeeding: Lovastatin is contraindicated during pregnancy and nursing due to potential harm to developing babies
  • Muscle disorders: Individuals with a history of muscle problems should be closely monitored, as statins can cause serious muscle damage
  • Kidney impairment: Patients with severe kidney disease may require dosage adjustments or alternative treatments
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and require careful monitoring

Interactions

Lovastatin has several important drug interactions that can increase the risk of serious side effects:

  • Cyclosporine: Significantly increases lovastatin levels, raising the risk of muscle damage
  • Gemfibrozil and other fibrates: Combined use increases the risk of severe muscle problems
  • Certain antibiotics (erythromycin, clarithromycin): Can increase lovastatin concentrations and toxicity risk
  • Antifungal medications (itraconazole, ketoconazole): May dramatically increase lovastatin levels
  • Grapefruit juice: Contains compounds that can increase drug levels when consumed in large quantities
  • HIV protease inhibitors: Can significantly elevate lovastatin concentrations
  • Warfarin: Lovastatin may enhance the blood-thinning effects, requiring careful monitoring
  • Digoxin: Statin use may slightly increase digoxin levels

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for lovastatin range from 20 mg to 80 mg taken once daily with the evening meal, as cholesterol synthesis is highest at night. Most patients start with 20 mg daily, with dosage adjustments made based on cholesterol response and tolerance. The maximum recommended dose is 80 mg daily, though this higher dose is associated with increased risk of muscle-related side effects. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific cardiovascular risk factors, cholesterol levels, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lovastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/lovastatin-4/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Atorvastatin

By
GMJ News Desk
01/06/2026

Fluvastatin

By
GMJ News Desk
01/06/2026

Lovastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up